» Articles » PMID: 32311998

Prediction Mode of More Than 5 Central Lymph Nodes Metastases in Clinically Node-negative Ipsilateral Papillary Thyroid Carcinoma with Tumor Size 1 to 4 cm

Overview
Specialty General Medicine
Date 2020 Apr 22
PMID 32311998
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

According to the 2015 American Thyroid Association guidelines, either lobectomy or total thyroidectomy was recommended for patients with papillary thyroid carcinoma (PTC) of 1 to 4 cm without extrathyroidal extension and lymph node metastasis. However, lymph node metastases showed strong association with recurrence and low survival rate, especially in PTC patients with more than 5 metastatic lymph nodes. Therefore, this study aimed to investigate the predictive factors of more than 5 central lymph nodes metastases (CLNM) in PTC patients with tumor sizes of 1 to 4 cm. A total of 382 patients with clinically node-negative (cN0) ipsilateral PTC who underwent thyroidectomy with central neck dissection between January 2012 and December 2016 were retrospectively analyzed. CLNMs of >5 were found in 54 (14.1%) patients, while CLNM was detected in 230 (60.2%) patients. Multivariate logistic regression revealed age < 45 years (P < .001), male gender (P = .013), and tumor sizes of >2 cm (P = .001) as independent predictive factors of >5 CLNMs in cN0 ipsilateral PTC patients with tumor sizes 1 to 4 cm. The prediction equation (Y = 1.694 × age + 0.807 × gender + 1.190 × tumor size - 3.530) was developed, with a sensitivity (57.4%) and a specificity (80.8%), respectively, at an optimal cut-off point of -1.685. Therefore, if the predictive value was higher than -1.685 according to the equation in cN0 ipsilateral PTC patients with tumor sizes 1 to 4 cm, then total thyroidectomy might be considered.

Citing Articles

Predictive Values of Clinical Features and Multimodal Ultrasound for Central Lymph Node Metastases in Papillary Thyroid Carcinoma.

Fu J, Liu J, Wang Z, Qian L Diagnostics (Basel). 2024; 14(16).

PMID: 39202260 PMC: 11353660. DOI: 10.3390/diagnostics14161770.


Analysis of factors influencing the clinical outcome after surgery and I therapy in patients with moderate-risk thyroid papillary carcinoma.

Li Y, Rao M, Zheng C, Huang J, Fang D, Xiong Y Front Endocrinol (Lausanne). 2022; 13:1015798.

PMID: 36313750 PMC: 9613939. DOI: 10.3389/fendo.2022.1015798.


The impact of thyroid tumor features on lymph node metastasis in papillary thyroid carcinoma patients in head and neck department at KAMC: A retrospective cross-sectional study.

Aljohani A, Merdad R, Alserif A, Alhemayed L, Farsi N, Alsufyani T Ann Med Surg (Lond). 2021; 64:102217.

PMID: 33854770 PMC: 8027685. DOI: 10.1016/j.amsu.2021.102217.

References
1.
Donangelo I, Walts A, Bresee C, Braunstein G . LYMPHOCYTIC THYROIDITIS IS ASSOCIATED WITH INCREASED NUMBER OF BENIGN CERVICAL NODES AND FEWER CENTRAL NECK COMPARTMENT METASTATIC LYMPH NODES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER. Endocr Pract. 2016; 22(10):1192-1198. DOI: 10.4158/E151078.OR. View

2.
Miyauchi A . Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid. World J Surg. 2016; 40(3):516-22. PMC: 4746213. DOI: 10.1007/s00268-015-3392-y. View

3.
Guerrero M, Clark O . Controversies in the management of papillary thyroid cancer revisited. ISRN Oncol. 2011; 2011:303128. PMC: 3197013. DOI: 10.5402/2011/303128. View

4.
Roh J, Kim J, Park C . Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol. 2011; 18(8):2245-50. DOI: 10.1245/s10434-011-1600-z. View

5.
Carty S, Cooper D, Doherty G, Duh Q, Kloos R, Mandel S . Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009; 19(11):1153-8. DOI: 10.1089/thy.2009.0159. View